Life Sciences / Healthcare
As in other sectors, life sciences and healthcare companies are increasingly reviewing their costs and manufacturing structures. Production and sourcing are migrating to low-cost regions of the world and, in consequence, supply chains are getting longer and more complex. Longer chains inevitably contain more stock, which imposes additional costs and risk.
Efficient global supply chains are essential - for example delivery of medicines and care products to exactly where and when they are needed. For this reason many businesses are embracing supply chain cooperation initiatives - such as DHL's shared-user warehousing and campus solutions. The highly regulated life sciences and healthcare market presents the supply chain industry with a unique set of challenges. Thanks to the technology at our disposal, our compliance with industry regulations and stringent security procedures, DHL is in an ideal position to meet the sector's demands.
We invest heavily in IT-based visibility tools to provide track-and-trace, with the opportunity to intervene if, for example, medical supplies are required in an emergency.
Our DHL Life Science Competency Centres and DHL Cold Chain solutions are market leading solutions and recognised leaders in handling cold chain products globally. The dedicated sites and staff are trained and experienced in the transport of temperature sensitive life science and healthcare products. Our qualification process and customised standard handling procedures provide the necessary infrastructure to ensure products are transported at the highest quality levels.
Our credentials in the highly regulated life sciences and healthcare sector are second to none, and customers include major pharmaceutical manufacturers and wholesalers, drug store groups, medical device manufacturers, health authorities, hospitals, health centres, hospital supply companies and other healthcare providers.
We offer a global network of purpose-built specialised clinical trials cells, providing highly controlled and monitored environments for clinical trials logistics.
DHL also operates direct-to-store pharmaceutical supply chains to optimise the supply chain; it also increases security and reduces handling - thereby helping to maintain product integrity.
As for the delivery of non-marketed medical products to individuals and study centres, we provide international air freight, break-bulk and cross-dock services to ensure the collection of drugs, medical devices and diagnostic kits from manufacturing plants and their time-sensitive distribution worldwide.
DHL Life Sciences and Healthcare is focusing their strategy on:
- clinical trials
- competence centres globally
- direct to pharmacy and hospitals
- regional hubs
- direct injection
- multi-user warehouses
- product launches.
These seven initiatives will help us to bring more value to the complete supply chain of our customers and become an integral part of bringing medicine to the patients.
For more information, please contact
DHL
DHL
DHL International, GmbH. All Rights Reserved